Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation

NCT00918346 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Tafluprost 0.0015%

Sponsor

Santen Oy